---
figid: PMC10521377__IID3-11-e1032-g001
pmcid: PMC10521377
image_filename: IID3-11-e1032-g001.jpg
figure_link: /pmc/articles/PMC10521377/figure/iid31032-fig-0004/
number: Figure 4
figure_title: ''
caption: 'Effect of cathelicidin (LL‐37) on the biological behavior of human coronary
  artery endothelial cells (HCAECs) cells by modulating the toll‐like receptors 4
  (TLR4)‐NF‐κB signaling pathway. (A) Apoptosis by flow cytometry; (B) transwell invasion
  assay (crystal violet staining, 400×, scale bar, 50 μm); (C) transmission electron
  microscopy observation (25,000×, Scale bar, 500 nm); (D) cell absorbance value at
  450 nm. The data are expressed as the mean ± SD. Compared with the control group,
  **p < .01. Compared with the LL‐37 group, #p < .05 ##p < 0.01.'
article_title: Cathelicidin (LL‐37) causes expression of inflammatory factors in coronary
  artery endothelial cells of Kawasaki disease by activating TLR4–NF‐κB–NLRP3 signaling.
citation: Feifei Si, et al. Immun Inflamm Dis. 2023 Sep;11(9):e1032.
year: '2023'

doi: 10.1002/iid3.1032
journal_title: Immunity, Inflammation and Disease
journal_nlm_ta: Immun Inflamm Dis
publisher_name: John Wiley and Sons Inc.

keywords:
- inflammatory response
- Kawasaki disease
- LL‐37
- NLRP3
- toll‐like receptors 4

---
